FBIO - Fortress Biotech, Inc.
IEX Last Trade
2
0.025 1.250%
Share volume: 3,285
Last Updated: Thu 26 Dec 2024 08:28:12 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.98
0.03
1.27%
Summary score
9%
Profitability
0%
Dept financing
20%
Liquidity
74%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-36.37%
Return on assets
-9.13%
Return on sales
-157.9%
Return on invested capital
-64.78%
Total debt ratio
81.28%
Debt ratio change over timeo
-0.76%
Current Ratio
3.23%
Quick Ratio
3.22%
Cash Position Ratio
2.59%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-32.59%
Return on assets
-10.08%
Return on sales
-239.86%
Return on invested capital
-79.57%
Total debt ratio
79.2%
Debt ratio change over timeo
-1.91%
Current Ratio
4.09%
Quick Ratio
4.07%
Cash Position Ratio
3.59%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-16.01%
Return on assets
-8.05%
Return on sales
-251.27%
Return on invested capital
-74.53%
Total debt ratio
67.18%
Debt ratio change over time
-1.6%
Current Ratio
6.38%
Quick Ratio
6.35%
Cash Position Ratio
5.86%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-112.95%
Return on assets
-102.06%
Return on sales
-188.57%
Return on invested capital
-91.16%
Total debt ratio
-75.79%
Debt ratio change over time
-0.76%
Current Ratio
0.53%
Quick Ratio
0.53%
Cash Position Ratio
0.42%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FBIO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -36.37% | -3.65% | 12.3% | 6.42% |
| Return on assets | -9.13% | 3.5% | 3.6% | 5.35% |
| Return on sales | -157.9% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | -64.78% | 4.99% | 7.81% | 13.62% |
| Profitability | 0% | 44% | 81% | 83% |
| Total debt ratio | 81.28% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.76% | 224.03% | 6.03% | 1.46% |
| Dept financing | 20% | 50% | 19% | 8% |
| Current Ratio | 4.09% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 4.07% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 3.59% | 1.41% | 0.73% | 1.41% |
| Liquididy | 72% | 27% | 54% | 61% |
| Short-term ratios | FBIO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -32.59% | -16.17% | 18.05% | 7.63% |
| Return on assets | -10.08% | 2.71% | 3.58% | 5.03% |
| Return on sales | -239.86% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | -79.57% | 6.54% | 5.97% | 19.39% |
| Profitability | 0% | 43% | 75% | 85% |
| Total debt ratio | 79.2% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -1.91% | 851.68% | 10.97% | 0.58% |
| Dept financing | 20% | 50% | 21% | 8% |
| Current Ratio | 4.09% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 4.07% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 3.59% | 1.41% | 0.73% | 1.41% |
| Liquididy | 75% | 34% | 26% | 48% |